Sleep Apnea, Central Terminated Phase 4 Trials for Zopiclone (DB01198)

Also known as: Central Sleep Apnea / Sleep Apnea Central / Central sleep apnoea syndrome / Central sleep apnea syndrome (disorder) / Central sleep apnea syndrome

IndicationStatusPhase
DBCOND0003369 (Sleep Apnea, Central)Terminated4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02820441Benefit of One Month Zopiclone Intake on Adaptative Servoventilation ComplianceSupportive Care